Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epithelial cells and fibroblasts.

S I Rennard1

  • 1University of Nebraska Medical Center, Pulmonary and Critical Care Medicine Section, Omaha, NE 68198-5300, USA.

Novartis Foundation Symposium
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sphingosylphosphorylcholine induces α-smooth muscle actin expression in human lung fibroblasts and fibroblast-mediated gel contraction via S1P2 receptor and Rho/Rho-kinase pathway.

Prostaglandins & other lipid mediators·2014
Same author

PDE4: a novel target in the treatment of chronic obstructive pulmonary disease.

Clinical pharmacology and therapeutics·2011
Same author

Epithelial cells modulate genes associated with NF kappa B activation in co-cultured human macrophages.

Immunobiology·2011
Same author

Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic.

Clinical pharmacology and therapeutics·2011
Same author

Candidate genes for COPD in two large data sets.

The European respiratory journal·2010
Same author

Statins inhibit matrix metalloproteinase release from human lung fibroblasts.

The European respiratory journal·2009
Same journal

Genetic and therapeutic control of diabetogenic CD8+ T cells.

Novartis Foundation symposium·2009
Same journal

Translating mucosal antigen based prevention of autoimmune diabetes to human.

Novartis Foundation symposium·2009
Same journal

Re-establishing immune tolerance in type 1 diabetes via regulatory T cells.

Novartis Foundation symposium·2009
Same journal

Immune markers of disease and therapeutic intervention in type 1 diabetes.

Novartis Foundation symposium·2009
Same journal

Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass.

Novartis Foundation symposium·2009
Same journal

CD8 and cytotoxic T cells in type 1 diabetes.

Novartis Foundation symposium·2009
See all related articles

Chronic obstructive pulmonary disease (COPD) involves airway and alveolar cell changes. Inflammatory and parenchymal cells interact, altering lung structure and function in COPD.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Pathophysiology

Background:

  • Chronic obstructive pulmonary disease (COPD) is marked by cellular and structural changes in airways and alveoli.
  • Increased inflammatory cells in airways are a key feature of COPD.
  • Airway parenchymal cells play a role in inflammatory cell recruitment and activation.

Purpose of the Study:

  • To explore the roles of airway parenchymal cells in COPD pathophysiology.
  • To understand the bidirectional interactions between inflammatory and parenchymal cells in COPD.
  • To investigate how cellular changes contribute to structural alterations and impaired lung function in COPD.

Main Methods:

  • Review of existing literature on cellular mechanisms in COPD.
  • Analysis of cellular interactions within the airway microenvironment.

Related Experiment Videos

  • Correlation of cellular behavior with structural changes and functional outcomes.

    • Main Results:

    • Parenchymal cells are crucial in recruiting and activating inflammatory cells.
    • Inflammatory cells modulate parenchymal cell behavior.
    • Cellular interactions lead to structural remodeling, affecting lung function.
    • Epithelial cells and fibroblasts influence each other's activity.

    Conclusions:

    • Cellular dynamics, including interactions between inflammatory cells, epithelial cells, and fibroblasts, are central to COPD pathogenesis.
    • These cellular activities contribute significantly to airway structural changes and functional decline in COPD.
    • Targeting these cellular interactions may offer therapeutic strategies for COPD.